ReviewAmerican journal of hematology2019
Treatment-free remission with first- and second-generation tyrosine kinase inhibitors.
Jorge Cortes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
63 papers cite itlatest 60 shown
this papertrialcites it